Nataly Kravchenko-Balasha (N Kravchenko-Balasha)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

NPJ systems biology and applications

International journal of molecular sciences

Genome medicine

NPJ breast cancer

Hebrew University of Jerusalem

Hebrew University of Jerusalem The Alexander Silberman Institute of Life Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hebrew University of Jerusalem

Israel

Senior lecture (assistant professor) :: Bio-medical sciences department. Faculty of Dental Medicine

California Institute of Technology

United States

EMBO Postdoctoral research fellow :: Physical Chemistry

Hebrew University of Jerusalem Faculty of Science

Israel

Postdoctoral research fellow :: Theoretical Chemistry

Hebrew University of Jerusalem The Alexander Silberman Institute of Life Sciences

Israel

Research and Teaching assistant :: Biochemistry

Education History

Hebrew University of Jerusalem The Alexander Silberman Institute of Life Sciences

Israel

PHD

Hebrew University of Jerusalem The Alexander Silberman Institute of Life Sciences

Israel

MSC

Hebrew University of Jerusalem Faculty of Science

Israel

BSC

Publications

Lisa Uechi, Swetha Vasudevan, Daniela Vilenski, Sergio Branciamore, David E Frankhouser, Denis O'Meally, Soheil Meshinchi, Guido Marcucci, Ya-Huei Kuo, Russell C Rockne, Nataly Kravchenko-Balasha
Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia. NPJ systems biology and applications 10 (1) (2024)
Lisa Uechi, Swetha Vasudevan, Daniela Vilenski, Sergio Branciamore, David E Frankhouser, Denis O'Meally, Soheil Meshinchi, Guido Marcucci, Ya-Huei Kuo, Russell C Rockne, Nataly Kravchenko-Balasha
Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia. NPJ systems biology and applications 10 (1) (2024)
Lisa Uechi, Swetha Vasudevan, Daniela Vilenski, Sergio Branciamore, David E Frankhouser, Denis O'Meally, Soheil Meshinchi, Guido Marcucci, Ya-Huei Kuo, Russell C Rockne, Nataly Kravchenko-Balasha
Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia. NPJ systems biology and applications 10 (1) (2024)
Lisa Uechi, Swetha Vasudevan, Daniela Vilenski, Sergio Branciamore, David E Frankhouser, Denis O'Meally, Soheil Meshinchi, Guido Marcucci, Ya-Huei Kuo, Russell C Rockne, Nataly Kravchenko-Balasha
Transcriptome free energy can serve as a dynamic patient-specific biomarker in acute myeloid leukemia. NPJ systems biology and applications 10 (1) (2024)
Nadin Rabah, Fatima-Ezzahra Ait Mohand, Nataly Kravchenko-Balasha
Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers. International journal of molecular sciences 24 (18) (2023)
Muhammad AbdEl-Haq, Awanish Kumar, Fatima-Ezzahra Ait Mohand, Nataly Kravchenko-Balasha, Yakir Rottenberg, Abraham Avi J Domb
Paclitaxel Delivery to the Brain for Glioblastoma Treatment. International journal of molecular sciences 24 (14) (2023)
Heba Alkhatib, Ariel M Rubinstein, Swetha Vasudevan, Efrat Flashner-Abramson, Shira Stefansky, Sangita Roy Chowdhury, Solomon Oguche, Tamar Peretz-Yablonsky, Avital Granit, Zvi Granot, Ittai Ben-Porath, Kim Sheva, Jon Feldman, Noa E Cohen, Amichay Meirovitz, Nataly Kravchenko-Balasha
Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance. Genome medicine 14 (1) (2022)
Tamar Zahavi, Mali Salmon-Divon, Roberto Salgado, Michael Elkin, Esther Hermano, Ariel M Rubinstein, Prudence A Francis, Angelo Di Leo, Giuseppe Viale, Evandro de Azambuja, Lieveke Ameye, Christos Sotiriou, Asher Salmon, Nataly Kravchenko-Balasha, Amir Sonnenblick
Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer. NPJ breast cancer 7 (1) (2021)
Swetha Vasudevan, Ibukun A Adejumobi, Heba Alkhatib, Sangita Roy Chowdhury, Shira Stefansky, Ariel M Rubinstein, Nataly Kravchenko-Balasha
Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures. Cancers 13 (19) (2021)
S Vasudevan, E Flashner-Abramson, Heba Alkhatib, Sangita Roy Chowdhury, I A Adejumobi, D Vilenski, S Stefansky, A M Rubinstein, Nataly Kravchenko-Balasha
Overcoming resistance to BRAFV600E inhibition in melanoma by deciphering and targeting personalized protein network alterations. NPJ precision oncology 5 (1) (2021)
Nataly Kravchenko-Balasha
Translating Cancer Molecular Variability into Personalized Information Using Bulk and Single Cell Approaches. Proteomics 20 (13) (2020)
Nataly Kravchenko-Balasha, D J Aframian
A novel strategy for diagnosing viral vs bacterial infection: implications for oral diseases. Oral diseases 24 (4) (2017)

Nataly Kravchenko-Balasha.css-eqlu8i{font-size:small;padding-left:4px;} (N Kravchenko-Balasha)

Publication Activity (10 Years)

Top Topics

Top Venues

Nataly Kravchenko-Balasha (N Kravchenko-Balasha)